Patrick Turko

15PUBLICATIONS
122CO-AUTHORS
Gene and molecular therapyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsiesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 26, 2026
NGFR induces melanoma invasion and immunotherapy resistance through myosin light chain 2 modulation.

|Jul 02, 2025
p62 mRNA suppresses NLRP1 expression in cutaneous SCC cells through miR-34a-5p.

Paulina Hennig, Patrick Turko, Michela Di Filippo

|Jun 26, 2025
Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints Targeted.

Lukas Kraehenbuehl, Nicola Winkelbeiner, Patrick Turko

|Dec 31, 2024
Anti-CTLA4 treatment reduces lymphedema risk potentially through a systemic expansion of the FOXP3+ Treg population.

Stefan Wolf, Matiar Madanchi, Patrick Turko

|Sep 14, 2024
Distinct Variations in Gene Expression and Cell Composition across Lichen Planus Subtypes.

Cadri Knoch, Veronika Baghin, Patrick Turko

|Jun 25, 2024
COL10A1 expression distinguishes a subset of cancer-associated fibroblasts present in the stroma of high-risk basal cell carcinoma.

Mauro Esposito, Laura Yerly, Prachi Shukla

Pageof 3

Frequent Collaborators

11 joint publications

Mitchell P Levesque

8 joint publications

Reinhard Dummer

4 joint publications

Phil F Cheng

4 joint publications

Ramon Staeger